Florence van Hunsel
Florence van Hunsel
Head Signal detection, Netherlands Pharmacovigilance Centre Lareb
Verified email at lareb.nl
Title
Cited by
Cited by
Year
Adverse drug reaction reporting by patients in The Netherlands three years of experience
J de Langen, F van Hunsel, A Passier, L de Jong-van den Berg, ...
Drug Safety 31 (6), 515-524, 2008
2102008
Experiences with adverse drug reaction reporting by patients
F van Hunsel, L Härmark, S Pal, S Olsson, K van Grootheest
Drug safety 35 (1), 45-60, 2012
1672012
Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an …
F Van Hunsel, A Passier, K Van Grootheest
British journal of clinical pharmacology 67 (5), 558-564, 2009
1082009
Acute effects of nicotine on attention and response inhibition
EM Bekker, KBE Böcker, F Van Hunsel, MC Van Den Berg, JL Kenemans
Pharmacology Biochemistry and Behavior 82 (3), 539-548, 2005
792005
Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
F van Hunsel, C van der Welle, A Passier, E van Puijenbroek, ...
European journal of clinical pharmacology 66 (11), 1143-1150, 2010
772010
ADR reporting by the general public: lessons learnt from the Dutch and Swedish systems
L Härmark, F van Hunsel, B Grundmark
Drug safety 38 (4), 337-347, 2015
692015
The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case–control study
F van Hunsel, A Talsma, E van Puijenbroek, L de Jong‐van den Berg, ...
pharmacoepidemiology and drug safety 20 (3), 286-291, 2011
602011
Adverse drug reaction reports of patients and healthcare professionals—differences in reported information
L Rolfes, F van Hunsel, S Wilkes, K van Grootheest, E van Puijenbroek
Pharmacoepidemiology and drug safety 24 (2), 152-158, 2015
522015
The quality of clinical information in adverse drug reaction reports by patients and healthcare professionals: a retrospective comparative analysis
L Rolfes, F van Hunsel, L van der Linden, K Taxis, E van Puijenbroek
Drug safety 40 (7), 607-614, 2017
492017
Adverse food–drug interactions
A de Boer, F Van Hunsel, A Bast
Regulatory Toxicology and Pharmacology 73 (3), 859-865, 2015
472015
Adverse drug reactions of montelukast in children and adults
MG Haarman, F van Hunsel, TW de Vries
Pharmacology research & perspectives 5 (5), e00341, 2017
402017
The impact of experiencing adverse drug reactions on the patient’s quality of life: a retrospective cross-sectional study in the Netherlands
L Rolfes, F van Hunsel, K Taxis, E van Puijenbroek
Drug safety 39 (8), 769-776, 2016
402016
Are consumers ready to take part in the Pharmacovigilance System?—a Portuguese preliminary study concerning ADR reporting
C Matos, F van Hunsel, J Joaquim
European journal of clinical pharmacology 71 (7), 883-890, 2015
342015
The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015
F van Hunsel, S de Waal, L Härmark
Pharmacoepidemiology and drug safety 26 (8), 977-983, 2017
312017
Safety concerns reported by patients identified in a collaborative signal detection workshop using VigiBase: results and reflections from Lareb and Uppsala Monitoring Centre
S Watson, RE Chandler, H Taavola, L Härmark, B Grundmark, A Zekarias, ...
Drug safety 41 (2), 203-212, 2018
302018
Important information regarding reporting of adverse drug reactions: a qualitative study
L Rolfes, S Wilkes, F van Hunsel, E van Puijenbroek, K van Grootheest
International Journal of Pharmacy Practice 22 (3), 231-233, 2014
302014
What motivates patients to report an adverse drug reaction?
FPAM van Hunsel, EAAM ten Berge, SD Borgsteede, K van Grootheest
Annals of Pharmacotherapy 44 (5), 936-937, 2010
282010
Patient reporting of adverse drug reactions: an international survey of national competent authorities’ views and needs
C Matos, L Härmark, F van Hunsel
Drug safety 39 (11), 1105-1116, 2016
272016
Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins
F van Hunsel, E van Puijenbroek, L de Jong‐van den Berg, ...
Pharmacoepidemiology and drug safety 19 (1), 26-32, 2010
252010
Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring
L Härmark, F van Hunsel, E Hak, K van Grootheest
Vaccine 29 (10), 1941-1947, 2011
232011
The system can't perform the operation now. Try again later.
Articles 1–20